Shareholding disclosure
Santhera Pharmaceuticals Holding AG
Collectively declared rate
15.53%
Threshold
Crossed upwards
Timeline
Published
20.05.2009
Transaction
14.05.2009
Transfer date
15.05.2009
Voting rights breakdown
Declared beneficial owners · 3
A single, collectively filed disclosure: the voting-rights rate applies to the whole group, not to each person.
Notice details
Notification ID
TB95J00014
Beneficial owner
Ernesto Bertarelli
Declared address
Ernesto Bertarelli, 3780 Gstaad
Direct acquirer acts on behalf of Ares Life Sciences GP Ltd ("Ares"), at the same address as the direct acquirer ("Omega"). Ares is held by the beneficial owners through Kedge Capital Holdings (Jersey) Limited, at the same address as Omega. Omega is held by the beneficial owners through (i) the Landmark Limited Parternship, a limited partnership having its registered office at the same address as Omega and (ii) Bertarelli SCA, a partnership limited by shares having its registered office at 412, route d'Esch, L-1030 Luxembourg
insider24.ch
Never miss a market signal again
Need more? Discover the Pro plan